| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | 0.021 | 0.9 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.007 | 0.9 |